[{"Assets_0_Q2_USD":463559000.0,"CommonStockSharesOutstanding_0_Q2_shares":73676295.0,"EarningsPerShareBasic_1_Q2_USD":-0.27,"EarningsPerShareBasic_2_Q2_USD":-0.59,"EarningsPerShareDiluted_1_Q2_USD":-0.27,"EarningsPerShareDiluted_2_Q2_USD":-0.59,"NetIncomeLoss_1_Q2_USD":-19400000.0,"NetIncomeLoss_2_Q2_USD":-41211000.0,"StockholdersEquity_0_Q2_USD":257740000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":71101336.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":69679746.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":71101336.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":69679746.0,"Ticker":"KDNY","CIK":"1435049","name":"ADURO BIOTECH, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170802"}]